Emergent Biosolutions (EBS) Misses Q3 EPS by 4c
Tweet Send to a Friend
Emergent Biosolutions (NYSE: EBS) reported Q3 EPS of $0.18, $0.04 worse ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
